Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsDaliah Ross, Molly Split, Zachary J Kunicki, et al.
Journal of the International Neuropsychological Society : JINS|August 18, 2025
Cognitive trajectories in older adults with essential tremorSamantha A Dargie, Silvia Chapman, Sandra Rizer, et al.
International Journal of Geriatric Psychiatry|May 30, 2026
The Role of Apathy in the Association Between Depressive Symptoms and Subjective Cognitive ComplaintsMegan S Barker, Jillian L Joyce, Leah Waltrip, et al.
Parkinsonism & Related Disorders|March 4, 2018
Self-report depressive symptoms are dissociated from tremor severity in essential tremorEdward D Huey, Stephanie Cosentino, Silvia Chapman, et al.
Parkinsonism & Related Disorders|April 14, 2022
Depressive symptoms predict memory decline in Essential TremorJennifer R Miller, Silvia Chapman, Daniella Iglesias Hernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Evaluation of Amyloid Removal as a Surrogate for Cognitive Decline: Pilot Analysis in Individual-Level Data from the A4 Study of SolanezumabSarah F Ackley, Michael Flanders, Audrey Murchland, et al.
Frontiers in Aging Neuroscience|April 4, 2022
Subjective Cognitive Decline Is More Accurate When Metamemory Is BetterSilvia Chapman, Jillian L Joyce, Megan S Barker, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 14, 2011
The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injuryFrank Krueger, Matteo Pardini, Edward D Huey, et al.
Neurology|July 11, 2014
Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disordersMary Kay Floeter, Rohan Katipally, Meredith P Kim, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 17, 2026
Evaluation of amyloid change as a surrogate for cognitive decline: demonstration in individual-level data from the A4 study of solanezumabSarah F Ackley, Michael D Flanders, Audrey Murchland, et al.
Pageof 20